Proteomics of bronchoalveolar lavage fluid

被引:107
作者
Wattiez, R [1 ]
Falmagne, P [1 ]
机构
[1] Univ Mons, Dept Biol Chem, B-7000 Mons, Belgium
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 815卷 / 1-2期
关键词
proteomics; bronchoalveolar lavage fluid;
D O I
10.1016/j.jchromb.2004.10.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lung diseases are essentially multi-factorial diseases that require a global analysis, and thus, cannot be understood through the sole analysis of individual or small numbers of genes. Proteome analysis has rapidly developed in the post-genome era and is now widely accepted as the obligated complementary technology for genetic profiling. It has been shown to be a powerful tool for the study of human diseases and for identifying novel prognostic, diagnostic and therapeutic markers. During last years, proteomic approaches applied to lung diseases are centred on the analysis of proteins in samples, such as cell cultures, biopsies and physiological fluids like serum and, especially, bronchoalveolar lavage fluid (BALF). BALF is presently the most common way of sampling the components of the epithelial lining fluid (ELF) and the most faithful reflect of the protein composition of the pulmonary airways. This review focuses on the state of the investigations of BALF proteome and its powerful contribution both to a better knowledge of the lung structure at the molecular level and to the study of lung disorders at the clinical level. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 85 条
[1]   High resolution mass spectrometric alveolar proteomics: Identification of surfactant protein SP-A and SP-D modifications in proteinosis and cystic fibrosis patients [J].
Bai, Y ;
Galetskiy, D ;
Damoc, E ;
Paschen, C ;
Liu, ZQ ;
Griese, M ;
Liu, SY ;
Przybylski, M .
PROTEOMICS, 2004, 4 (08) :2300-2309
[2]  
Barnouin Karin, 2004, Methods Mol Biol, V261, P479
[3]   Induced sputum methodology: Validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individuals [J].
Beier, J ;
Beeh, KM ;
Kornmann, O ;
Buhl, R .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2004, 144 (01) :38-44
[4]  
BELL DY, 1979, AM REV RESPIR DIS, V119, P979
[5]   Mass spectrometry-based proteomics: Current status and potential use in clinical chemistry [J].
Binz, PA ;
Hochstrasser, DF ;
Appel, RD .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (12) :1540-1551
[6]  
BLACKSTOCK W, 2000, PROTEOMICS TRENDS GU, V7, P1
[7]   Protein profiling in respiratory disease: techniques and impact [J].
Boggs, SE .
EXPERT REVIEW OF PROTEOMICS, 2004, 1 (01) :29-36
[8]   Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury [J].
Bowler, RP ;
Duda, B ;
Chan, ED ;
Enghild, JJ ;
Ware, LB ;
Matthay, MA ;
Duncan, MW .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 286 (06) :L1095-L1104
[9]   Lung hyperpermeability, CLARA-CELL secretory protein (CC16), and susceptibility to ozone of five inbred strains of mice [J].
Broeckaert, F ;
Clippe, A ;
Wattiez, R ;
Falmagne, P ;
Bernard, A .
INHALATION TOXICOLOGY, 2003, 15 (12) :1209-1230
[10]   Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present [J].
Chanin, TD ;
Merrick, DT ;
Franklin, WA ;
Hirsch, FR .
CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (04) :242-247